Stryker's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Stryker's ROA in the third quarter of 2026?
Stryker Corp achieved a return on average assets (ROA) of 7.58 % in its third quarter of 2026, which is below Stryker's average return on assets, which stands at 9.48%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 119 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 884, from total ROA ranking in the second quarter of 2026 at 1046.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	2.12 %	5.48 %	1.14 %	11.08 %	7.75 %
Y / Y Net Income Change	-12.34 %	44.34 %	13.91 %	55.49 %	3 %
Net Income (TTM) in million	3,623	3,729	3,337	3,246	2,943
Return On Assets (TTM)	7.58 %	7.85 %	7.11 %	6.94 %	6.46 %
SYK's Total Ranking	# 884	# 1046	# 960	# 959	# 946
Total Assets (TTM) in million	47,247	47,961	45,711	50,187	46,267
Seq. Total Assets Change	-1.49 %	4.92 %	-8.92 %	8.47 %	1.76 %
Seq. Net Income Change	-40.99 %	71.28 %	-12.25 %	-1.16 %	-2.83 %

SYK's 5 Years Annual ROA >> Back to SYK Management Effectiveness >> Compare SYK ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 35
Sector	# 120
Overall	# 806

Return On Assets Statistics
High	Average	Low
15.63 %	9.48 %	3 %
(June 30. 2007)		IV. Quarter

Financial Statements
Stryker's Assets	$ 47,247 million	SYK's Balance sheet
Stryker's Income	$ 753 million	Quarterly SYK's Income Statement
SYK's Income by Division		See SYK's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	11.08 %	7.84 %	13.59 %	6.51 %	0.88 %
Total Assets in million	50,187	45,181	41,895	36,884	34,631
Y / Y Net Income Change	8.45 %	-5.43 %	34.22 %	18.25 %	24.7 %
Net Income in million	3,246	2,993	3,165	2,358	1,994
Annual Return On Assets	6.47 %	6.62 %	7.55 %	6.39 %	5.76 %

SYK's 5 Years Annual ROA >> Back to SYK Management Effectiveness >> Compare SYK ROA to its Competitors

Comment on SYK's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 6.47 %, despite annual net income growth of 8.45 % to $3,246.00 million, from $2,993.00 million a year ago, as SYK's assets increase to $50,187.00 million, by 8.45 %.

More Return On Assets Ratios
SYK's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SYK's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SYK's Competitors
Subscribers only: Roa for Stryker's Suppliers
Subscribers only: Return On Assets for SYK's Customers

You may also want to know
SYK's Roi	SYK's Inventory Turnover Ratio	SYK's Growth Rates	SYK's Dividend Comparisons
	SYK's Profitability Ratios	SYK's Asset Turnover Ratio	SYK's Dividend Growth
SYK's Roe	SYK's Valuation Ratios	SYK's Financial Strength Ratios	SYK's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Beone Medicines Ltd	10.23 %
Amgen Inc	10.02 %
Bio rad Laboratories Inc	9.88 %

Date modified: 2026-10-31T10:02:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.